Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06180473
What this trial is testing

Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream

Who this might be right for
Psoriasis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Not applicableUnknownNCT05954572
What this trial is testing

Association Between Biologic Therapy and Demodex Density in Psoriasis Patients: A Comparative Study

Who this might be right for
Demodicidosis
Hasan Aksoy 34
Post-approval studies (Phase 4)Study completedNCT00462072
What this trial is testing

Centocor Microarray Study of Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisPsoriasis+1 more
University of Rochester 31
Not applicableNot Yet RecruitingNCT07793773
What this trial is testing

Disease Impact and Its Correlation With Disease Activity in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Assiut University 80
Post-approval studies (Phase 4)Looking for participantsNCT07160231
What this trial is testing

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek 200
Not applicableNot Yet RecruitingNCT07022756
What this trial is testing

Personalized Outreach for Equitable Treatment in Rheumatology

Who this might be right for
Rheumatic DiseasesInflammatory ArthritisRheumatoid Arthritis (RA)+2 more
University of British Columbia 20
Large-scale testing (Phase 3)Study completedNCT00115076
What this trial is testing

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Rockefeller University 31
Post-approval studies (Phase 4)Ended earlyNCT04028713
What this trial is testing

Dose Tapering Study of Adalimumab in Psoriasis

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 19
Early research (Phase 1)Study completedNCT05225623
What this trial is testing

Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid Obesity

Who this might be right for
Psoriatic ArthritisObesity
University of Calgary 38
Not applicableStudy completedNCT05647187
What this trial is testing

Effect Narrow-Band UVB Radiations

Who this might be right for
Psoriasis VulgarisUVB Phototherapy Burn
South Valley University 80
Early research (Phase 1)Study completedNCT01539915
What this trial is testing

Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 12
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Not applicableStudy completedNCT01320774
What this trial is testing

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 588
Large-scale testing (Phase 3)Study completedNCT00438360
What this trial is testing

Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 243
Not applicableStudy completedNCT02576197
What this trial is testing

Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients

Who this might be right for
Psoriasis
Biopolis S.L. 98
Early research (Phase 1)Study completedNCT00472758
What this trial is testing

Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545

Who this might be right for
Chronic Plaque Psoriasis
MedImmune LLC 40
Post-approval studies (Phase 4)Study completedNCT00967538
What this trial is testing

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Who this might be right for
Psoriasis
Innovaderm Research Inc. 89
Post-approval studies (Phase 4)Study completedNCT06032858
What this trial is testing

Efficacy and Safety of Apremilast in Psoriasis

Who this might be right for
Psoriasis
Ghurki Trust and Teaching Hospital 30
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Next Page